# Inhaled NO for the Treatment of Viral Pneumonia in Adults

> **NCT04606407** · NA · COMPLETED · sponsor: **Beyond Air Inc.** · enrollment: 40 (actual)

## Conditions studied

- Viral Pneumonia
- Nitric Oxide
- Respiratory Disease
- Pneumonia, Viral
- Inhaled Nitric Oxide
- Covid19
- SARS-CoV Infection

## Interventions

- **DEVICE:** LungFit™

## Key facts

- **NCT ID:** NCT04606407
- **Lead sponsor:** Beyond Air Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-25
- **Primary completion:** 2022-08-07
- **Final completion:** 2022-08-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04606407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04606407, "Inhaled NO for the Treatment of Viral Pneumonia in Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04606407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*